These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 10992176

  • 1. Resistance of pelvic arteries and plasma lipids in postmenopausal women: comparative study of tibolone and continuous combined estradiol and norethindrone acetate replacement therapy.
    Dören M, Rübig A, Coelingh Bennink HJ, Holzgreve W.
    Am J Obstet Gynecol; 2000 Sep; 183(3):575-82. PubMed ID: 10992176
    [Abstract] [Full Text] [Related]

  • 2. Differential effects on the androgen status of postmenopausal women treated with tibolone and continuous combined estradiol and norethindrone acetate replacement therapy.
    Dören M, Rübig A, Coelingh Bennink HJ, Holzgreve W.
    Fertil Steril; 2001 Mar; 75(3):554-9. PubMed ID: 11239541
    [Abstract] [Full Text] [Related]

  • 3. Effect of hormone replacement therapy, tibolone and raloxifene on serum lipids, apolipoprotein A1, apolipoprotein B and lipoprotein(a) in Greek postmenopausal women.
    Christodoulakos GE, Lambrinoudaki IV, Panoulis CP, Papadias CA, Kouskouni EE, Creatsas GC.
    Gynecol Endocrinol; 2004 May; 18(5):244-57. PubMed ID: 15346660
    [Abstract] [Full Text] [Related]

  • 4. Flow resistance in carotid and middle cerebral arteries in postmenopausal women: a comparative study of tibolone and continuous combined hormone replacement therapy.
    Pan HA, Wang ST, Chen CH, Pai MC, Wu MH, Huang KE.
    Climacteric; 2002 Sep; 5(3):259-65. PubMed ID: 12419084
    [Abstract] [Full Text] [Related]

  • 5. Effects of a continuous-combined regimen of low-dose hormone therapy (oestradiol and norethindrone acetate) and tibolone on the quality of life in symptomatic postmenopausal women: a double-blind, randomised study.
    Polisseni AF, Andrade AT, Ribeiro LC, Castro IQ, Brandão M, Polisseni F, Guerra Mde O.
    Maturitas; 2013 Feb; 74(2):172-8. PubMed ID: 23201326
    [Abstract] [Full Text] [Related]

  • 6. Effects of tibolone or continuous combined oestradiol and norethisterone acetate on lipids, high-density lipoprotein subfractions and apolipoproteins in postmenopausal women in a two-year, randomized, double-blind, placebo-controlled trial.
    Kotecha PT, Godsland IF, Crook D, Stevenson JC.
    Clin Endocrinol (Oxf); 2020 Apr; 92(4):303-311. PubMed ID: 31925799
    [Abstract] [Full Text] [Related]

  • 7. Impact on uterine bleeding and endometrial thickness: tibolone compared with continuous combined estradiol and norethisterone acetate replacement therapy.
    Dören M, Rübig A, Coelingh Bennink HJ, Holzgreve W.
    Menopause; 1999 Apr; 6(4):299-306. PubMed ID: 10614676
    [Abstract] [Full Text] [Related]

  • 8. Comparative effects of estrogens plus androgens and tibolone on bone, lipid pattern and sexuality in postmenopausal women.
    Castelo-Branco C, Vicente JJ, Figueras F, Sanjuan A, Martínez de Osaba MJ, Casals E, Pons F, Balasch J, Vanrell JA.
    Maturitas; 2000 Feb 15; 34(2):161-8. PubMed ID: 10714911
    [Abstract] [Full Text] [Related]

  • 9. Effects of low-dose 17-beta-estradiol plus norethisterone acetate and tibolone on fasting plasma homocysteine levels in postmenopausal women.
    Kaleli B, Yildirim B, Demir S, Alatas E.
    Acta Obstet Gynecol Scand; 2003 Dec 15; 82(12):1107-11. PubMed ID: 14616255
    [Abstract] [Full Text] [Related]

  • 10. Effects on serum lipid profiles of continuous 17beta-estradiol, intermittent norgestimate regimens versus continuous combined 17beta-estradiol/norethisterone acetate hormone replacement therapy.
    Ylikorkala O, Lim P, Caubel P.
    Clin Ther; 2000 May 15; 22(5):622-36. PubMed ID: 10868559
    [Abstract] [Full Text] [Related]

  • 11. The effects of continuous combined oral estradiol and norethisterone on pulsatility index in internal carotid and uterine arteries in early postmenopausal Taiwanese women---a preliminary study.
    Huang CY, Fu CY, Tseng JY, Yang TS, Chao KC.
    Taiwan J Obstet Gynecol; 2009 Mar 15; 48(1):60-4. PubMed ID: 19346194
    [Abstract] [Full Text] [Related]

  • 12. Changes in lipid and lipoprotein profile in postmenopausal women receiving low-dose combinations of 17beta-estradiol and norethisterone acetate.
    Samsioe G, Li C, Borgfeldt C, Wilawan K, Aberg A, Larsen S.
    Menopause; 2002 Mar 15; 9(5):335-42. PubMed ID: 12218722
    [Abstract] [Full Text] [Related]

  • 13. Effects of tibolone and continuous combined hormone replacement therapy on mammographic breast density.
    Lundström E, Christow A, Kersemaekers W, Svane G, Azavedo E, Söderqvist G, Mol-Arts M, Barkfeldt J, von Schoultz B.
    Am J Obstet Gynecol; 2002 Apr 15; 186(4):717-22. PubMed ID: 11967497
    [Abstract] [Full Text] [Related]

  • 14. Tibolone, oral or transdermal hormone replacement and colour Doppler analysis: a prospective, randomised pilot study.
    Battaglia C, Mancini F, Persico N, Penacchioni P, Regnani G, Volpe A, de Aloysio D.
    Maturitas; 2004 Aug 20; 48(4):446-55. PubMed ID: 15283938
    [Abstract] [Full Text] [Related]

  • 15. Economic impact of tibolone compared with continuous-combined hormone replacement therapy. In the management of postmenopausal women with climacteric symptoms in the UK.
    Plumb JM, Guest JF.
    Pharmacoeconomics; 2000 Nov 20; 18(5):477-86. PubMed ID: 11151401
    [Abstract] [Full Text] [Related]

  • 16. Effects of tibolone and combined 17beta-estradiol and norethisterone acetate on serum C-reactive protein in healthy post-menopausal women: a randomized trial.
    Garnero P, Jamin C, Benhamou CL, Pelissier C, Roux C.
    Hum Reprod; 2002 Oct 20; 17(10):2748-53. PubMed ID: 12351557
    [Abstract] [Full Text] [Related]

  • 17. Differing effects of low-dose estrogen-progestin therapy and pravastatin in postmenopausal hypercholesterolemic women.
    Davis SR, Goldstat R, Newman A, Berry K, Burger HG, Meredith I, Koch K.
    Climacteric; 2002 Dec 20; 5(4):341-50. PubMed ID: 12626213
    [Abstract] [Full Text] [Related]

  • 18. Tibolone, transdermal estradiol or oral estrogen-progestin therapies: effects on circulating allopregnanolone, cortisol and dehydroepiandrosterone levels.
    Pluchino N, Genazzani AD, Bernardi F, Casarosa E, Pieri M, Palumbo M, Picciarelli G, Gabbanini M, Luisi M, Genazzani AR.
    Gynecol Endocrinol; 2005 Mar 20; 20(3):144-9. PubMed ID: 16019353
    [Abstract] [Full Text] [Related]

  • 19. Effects of tibolone and continuous combined hormone replacement therapy on parameters in the clotting cascade: a multicenter, double-blind, randomized study.
    Winkler UH, Altkemper R, Kwee B, Helmond FA, Coelingh Bennink HJ.
    Fertil Steril; 2000 Jul 20; 74(1):10-9. PubMed ID: 10899490
    [Abstract] [Full Text] [Related]

  • 20. Effects of continuous estrogen and estrogen-progestin replacement regimens on cardiovascular risk markers in postmenopausal women.
    Davidson MH, Maki KC, Marx P, Maki AC, Cyrowski MS, Nanavati N, Arce JC.
    Arch Intern Med; 2000 Nov 27; 160(21):3315-25. PubMed ID: 11088095
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.